Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17467169 | 1.00 | CYP2C19 (0.42) | CYP2C19ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL15545353 | 0.83 | ALDH1A1 (0.39) | CYP2C19ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL15544172 | 0.81 | CYP2C19 (0.37) | CYP2C19ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL15544175 | 0.81 | CYP2C19 (0.37) | CYP2C19ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL17467134 | 0.77 | CYP2C19 (0.40) | CYP2C19ALDH1A1MAPTPKMPOLB | |
| SCHEMBL2209277 | 0.76 | ALDH1A1 (0.56) | ALDH1A1KMT2AMEN1MAPTHTT | |
| SCHEMBL2209281 | 0.76 | ALDH1A1 (0.56) | ALDH1A1KMT2AMEN1MAPTHTT | |
| SCHEMBL16680148 | 0.76 | CYP2C19 (0.39) | CYP2C19ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL1163006 | 0.75 | ALDH1A1 (0.45) | CYP2C19ALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL3318266 | 0.74 | CTSV (0.48) | CYP2C19ALDH1A1KMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9249160-B2 | Orexin receptor antagonists | HEPTARES THERAPEUTICS LIMITED (GB) | 2016-02-02 | — | — | US | disclosed |